A functional tonB gene is required for both virulence and competitive fitness in a chinchilla model of Haemophilus influenzae otitis media by Daniel J Morton et al.
Morton et al. BMC Research Notes 2012, 5:327
http://www.biomedcentral.com/1756-0500/5/327RESEARCH ARTICLE Open AccessA functional tonB gene is required for both
virulence and competitive fitness in a chinchilla
model of Haemophilus influenzae otitis media
Daniel J Morton1*, Randy J Hempel1,2, Thomas W Seale1, Paul W Whitby1 and Terrence L Stull1,2Abstract
Background: Haemophilus influenzae requires heme for aerobic growth and possesses multiple mechanisms to
obtain this essential nutrient.
Methods: An insertional mutation in tonB was constructed and the impact of the mutation on virulence and fitness
in a chinchilla model of otitis media was determined. The tonB insertion mutant strain was significantly impacted in
both virulence and fitness as compared to the wildtype strain in this model.
Conclusions: The tonB gene of H. influenzae is required for the establishment and maintenance of middle ear
infection in this chinchilla model of bacterial disease.Background
Haemophilus influenzae is a fastidious facultatively an-
aerobic Gram-negative bacterium that causes a range of
human infections including otitis media, meningitis, epi-
glottitis and pneumonia [1,2]. H. influenzae lacks all
enzymes in the biosynthetic pathway for the porphyrin
ring, and as a result is unable to synthesize protopor-
phyrin IX (PPIX), the immediate precursor of heme.
Since H. influenzae cannot synthesize PPIX the organ-
ism has an absolute growth requirement for an exogen-
ous source of either heme or PPIX in the presence of
iron [3,4]. As a result of this growth requirement, H.
influenzae has evolved a complex multifunctional array
of uptake mechanisms to ensure that it is able to utilize
available porphyrin or iron in vivo [5]. These mechan-
isms include numerous outer membrane proteins
(OMPs) that bind one or more host heme- and iron-
containing proteins including hemoglobin, hemoglobin-
haptoglobin, heme-hemopexin and heme-human serum
albumin complexes, and ferritransferrin [5–9]. All of
these H. influenzae OMPs that bind host heme- or iron-
containing proteins are TonB-dependent transporters
(TBDT) [5]. The outer membrane of Gram-negative* Correspondence: dmorton@ouhsc.edu
1Department of Pediatrics, University of Oklahoma Health Sciences Center,
Oklahoma City, Oklahoma 73104, USA
Full list of author information is available at the end of the article
© 2012 Morton et al.; licensee BioMed Central
Commons Attribution License (http://creativec
reproduction in any medium, provided the orbacteria hinders the uptake of essential nutrients, and,
while small molecules passively diffuse through porins,
substrates that are too large to pass through the porins
and/or are present at very low concentrations require
energized transport [10,11]. A cytoplasmic transmem-
brane protein complex composed of three proteins,
TonB, ExbB and ExbD, spans the periplasm and inter-
acts with specific TBDTs. This TonB complex transduces
the proton motive force of the cytoplasmic membrane to
energize transport of substrates through a specific TBDT
[10]. Mutations of many of the TBDTs of H. influenzae
have been shown to have significant impacts on viru-
lence in animal models of infection, for example
complete deletion of the complement of hemoglobin-
haptoglobin binding proteins (Hgps) in a nontypeable
strain significantly reduces the severity of middle ear in-
fection in the chinchilla model of otitis media [12]. Dele-
tion of the complement of hgps in a type b strain had a
significant impact on virulence in a weanling rat model
of bacteremia but not in a 5-day old infant rat model of
bacteremia [13]. Similarly, mutation of the heme-
hemopexin acquisition protein HxuC impacted virulence
in the weanling but not in the 5-day old infant rat [13].
However, a mutant strain lacking both the Hgps and
HxuC was unable to sustain bacteremia in 5-day old rats
[13]. Mutation of an additional TBDT designated Hup
(heme utilization protein) had no impact on virulence inLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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other proteins have been shown to be involved in heme
acquisition and in virulence in rat models of invasive
disease, including the periplasmic heme-binding protein
HbpA, lipoprotein e(P4) and the tellurite resistance pro-
tein TehB [14–16]. These data highlight the complexity
of the heme acquisition systems of H. influenzae and
their potential roles in virulence.
The tonB gene of H. influenzae has previously been
mutated and shown to be essential for the utilization of
transferrin bound iron, hemoglobin, hemoglobin-
haptoglobin, heme-hemopexin and low levels of heme
[17,18]. In addition a tonB mutant of the type b H.influ-
enzae strain Eagan was avirulent in an infant rat model
of bacteremia [17].
The goal of the present study was to determine if the
TonB system is essential for the establishment and
maintenance of otitis media in the chinchilla, a widely
used model of human otitis media.
Methods
Bacterial strains and growth conditions
Nontypeable H. influenzae strain 86-028NP is a minim-
ally passaged nasopharyngeal isolate from a pediatric pa-
tient who underwent tympanostomy and tube insertion
for chronic otitis media at Columbus Children’s Hos-
pital. Strain 86-028NP has been extensively character-
ized in chinchilla models of otitis media [19–21]. H.
influenzae was maintained long-term in 10% skim milk
at −80°C. H. influenzae was routinely grown on choc-
olate agar with bacitracin (BBL, Becton-Dickinson,
Sparks, MD, USA) at 37°C. When necessary, H. influen-
zae was grown on brain heart infusion (BHI) agar (Difco,
Becton-Dickinson, Sparks, MD, USA) supplemented
with 10 μg ml-1 heme and 10 μg ml-1 β-NAD (supple-
mented BHI; sBHI) and the appropriate antibiotic(s).
Heme-deplete growth was performed in BHI broth sup-
plemented with 10 μg ml-1 β-NAD alone (heme-deplete
BHI; hdBHI).
Heme sources
Human serum albumin (HSA), and heme (as hemin)
were purchased from Sigma. Stock heme solutions
(1 mg ml-1 heme in 4% v/v triethanolamine) were pre-
pared as previously described [22]. Heme-albumin com-
plexes were prepared as previously described [7].
Construction of a tonB insertional mutant
The genome of strain 86-028NP has been fully
sequenced [23], and the exbB, exbD and tonB genes in
this strain are designated with the locus numbers
NTHI0358, NTHI0359 and NTHI0360 respectively. An
insertional mutation in tonB (NTHI0360) was con-
structed as follows. A pair of primers was designed foruse in the PCR, based on the available H. influenzae
genomic sequence, to amplify an ~1930-bp region
encompassing the entire tonB gene. Primers were desig-
nated TONB-1 and TONB-2 and had the respective
sequences 5’-AATGGCAAGATCAAAACGG-3’ and 5’-
CCTTATGTTGGATTACTTGG-3’. PCRs were per-
formed in a 50 μl volume using 100 ng of H. influenzae
chromosomal DNA as template, and the reactions con-
tained 2 mM MgCl2, 200 μM each dNTP and 2 U of
FastStart Taq DNA Polymerase (Roche, Indianapolis, IN,
USA). The PCR was carried out for 30 cycles with each
cycle consisting of denaturation at 95°C for 1 min,
annealing for 1 min at 52°C and primer extension at 72°
C for 2 min with one final extension for 30 min. A PCR
product of the expected size was obtained and
successfully cloned into the TA cloning vector pCR2.1-
TOPO (Invitrogen); a plasmid harbouring the correct
insert was confirmed by automated sequencing and
designated pDJM15. pDJM15 was linearized at a unique
SspI restriction site within the coding sequence of tonB.
The zeocin resistance marker was excised from pEM7/
Zeo (Invitrogen) by digestion with EcoRV and PvuII and
the ~600-bp fragment containing the zeocin marker was
ligated to linearized pDJM15 to yield pDJM19. H. influ-
enzae strain 86-028NP was transformed to zeocin resist-
ance using pDJM19 by the static aerobic method as
previously described with selection on zeocin at
25 μg ml -1 [7,12]. A zeocin resistant 86-028NP transfor-
mant was confirmed as correct by sizing and sequencing
of a PCR product and was designated HI2280.
Growth studies
Growth studies were performed using the Bioscreen
C Microbiology Reader (Oy Growth Curves AB Ltd.,
Helsinki, Finland) as previously described [24,25].
Chinchilla models of otitis media
A total of 15 adult chinchillas (Chinchilla lanigera) with
no evidence of middle ear infection by either otoscopy
or tympanometry at the beginning of the study were
used. Animals were rested for at least 7 days upon ar-
rival to acclimate them to the vivarium. After acclima-
tion, chinchillas were challenged with H. influenzae in
two separate experiments.
In the first experiment groups of five chinchillas were
challenged in both ears transbullarly with approximately
2000 c.f.u. of either NTHi strain 86-028NP or its tonB
mutant derivative HI2280 in order to compare virulence
of the two strains. Transbullar inocula were delivered in
300 μl 0.1% gelatin in PBS by direct injection of bacterial
suspensions into the superior bullae. Actual challenge
dosages received were confirmed by plate count. On
days 4, 7, 11, 14 and 17 days post challenge middle ear
effusions (MEE) were collected by epitympanic tap, i.e.
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1.5 inch 25-gauge hypodermic needle [26]. On epitympa-
nic tap the minimum amount of fluid required to per-
form a dilution series and plating to determine bacterial
titers was withdrawn. Ears were scored as “dry” (i.e. no
detectable MEE) when an ear was successfully tapped
and no evidence of effusion was seen when the plunger
of a 1 ml syringe was pulled back maximally. In some
cases ears were scored as “ISVP” (insufficient volume to
plate) when there was any evidence of effusion, which in
some cases manifested as bubbles in the hub of the syr-
inge, but the volume was insufficient to perform a dilu-
tion series. Although bacterial titers could not be
determined for ISVP ears such ears were considered
positive for the presence of MEE.
Bacterial titers were determined using a modification
of the track-dilution method of Jett et al as previously
described [7,27]. Serial dilutions (0 to 10-5) of freshly
recovered MEE were made in 0.1% gelatin in PBS and
10 μl aliquots from each dilution were plated in
triplicate on sBHI and all plates were incubated at 37°C
for 48 hours to quantify c.f.u. NTHi ml -1. Since heme is
not required for anaerobic growth plates were incubated
both aerobically and anaerobically to remove any
potential impact of the tonB mutation on detection of
bacteria.
In the second experiment a group of 5 chinchillas was
challenged transbullarly with an inoculum containingFigure 1 - Growth of H. influenzae strains with either free heme or th
Growth of the nontypeable H. influenzae strain 86-028NP and the tonb inse
heme-human serum albumin as the sole heme source. Wildtype strain 86-0
serum albumin at 50 ng ml-1 heme equivalent (open circles). The tonB mut
heme-human serum albumin at 50 ng ml-1 heme equivalent (open triangle
experiments. Using the Mann Whitney test to compare growth of 86-028N
source P< 0.0001.equal numbers of NTHi strain 86-028NP and its tonB
mutant derivative HI2280 (total of approximately 2500
c.f.u.) to quantify differential fitness of the two strains.
All ears were tapped for collection of MEE on days 4, 7,
11, 15 and 18 days post infection. Each recovered MEE
was plated on sBHI and on sBHI containing 7.5 μg ml -1
zeocin to determine total bacterial titer and the titer of
the mutant strain respectively (7.5 μg ml -1 zeocin was
used in these experiments since it is the lowest concen-
tration we have found to be adequate for differentiation
of zeocin-sensitive and zeocin-resistant strains). The
competitive index (CI) was calculated for all ears at all
time-points in experiment 2 and is defined as the ratio
of the output mutant/wildtype ration to the input mu-
tant/wildtype ratio.
Animal procedures have been described in detail else-
where [19,26,28]. The protocol for use of animals in this
study was reviewed and approved by the Institutional
Animal Care and Use Committee of the University of
Oklahoma Health Sciences Center.
Statistics
Statistical comparisons of growth between strains under
the same growth conditions in vitro were made using
the Mann–Whitney test. Percentages of infected ears
yielding a detectable effusion and percentages of effu-
sions with detectable wildtype or mutant bacteria were
compared using Fisher’s Exact test.e heme-hemun serum albumin complex as the sole heme source.
rtion mutant strain HI2280 in hdBHI supplemented with heme or
28NP with heme at 10 μg ml-1 (solid circles) and with heme-human
ant strain HI2280 with heme at 10 μg ml-1 (solid triangles) and with
s). Results are mean± SD for quintuplicate results from representative
P and HI2280 over the entire 24 hour growth period in either heme
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Excel v2.22 (Analyze-It Software Inc., Leeds, England). A
P value< 0.05 was taken as statistically significant.
Results and discussion
An insertional mutation in the tonB gene of H. influen-
zae strain 86-028NP was constructed as described in the
Methods section. The tonB mutant strain (HI2280) con-
tains a zeocin resistance marker disrupting codon 147 ofFigure 2 – Percentage of infected ears yielding a middle ear effusion
successfully tapped ears infected with either the wildtype strain 86-028NP
yielding a middle ear effusion. Using Fisher’s Exact test to compare percen
days: on day 4 P= 0.0325, on day 7 P= 0.0007, on day 10 P= 0.0004, on day
effusions from ears infected with the wildtype strain 86-028NP (black colum
day 4 from ears infected with the tonB mutant strain HI2280. On days 7 thr
with the tonB mutant strain HI2280.the tonB gene. To confirm the anticipated phenotype,
the tonB mutant was compared to the wildtype strain in
growth curve analyses for the ability to utilize various
porphyrin sources. The mutant strain grew significantly
less well than the wildtype strain in heme at 10 μg ml-1
and did not grow at all in heme-HSA at 50 ng ml-1 heme
equivalent (Figure 1). In addition the tonB mutation
abrogated the ability to utilize either heme at lower con-
centrations or hemoglobin-haptoglobin complexes as theand bacterial titers in middle ear effusions. A) Percentage of
(black columns) or the tonB mutant strain HI2280 (grey columns)
tages of ears infected with either strain yielding effusions on given
14 P= 0.0256 and on day 17 P= 0.015. B) Bacterial titers in middle ear
ns). No bacteria were detected in middle ear effusions recovered on
ough 17 no middle ear effusions were recovered from ears infected
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with respect to the impact of a tonB mutation on heme
source utilization are further supported by the data of
Jarosik et al [17,18], who demonstrated in two type b
strains and one nontypeable strain that mutation of tonB
abrogated the ability to utilize various heme sources
including heme, hemoglobin-haptoglobin and heme-
hemopexin. Jarosik et al also showed that complementa-
tion of the tonB mutation with the complete exbB exdD
tonB operon corrected the in vitro phenotypes. However,
repeated attempts to complement the mutation in strain
86-028NP using various strategies have been unsuccess-
ful to date. We initially attempted to clone the entire
exbBexbDtonB operon, in order to drive production
from the native promoter, in E. coli in both high-copy
and low-copy number plasmids; cloning in E. coli failed
presumably due to toxicity. Subsequently we attempted
to clone the operon directly into H. influenzae using ei-
ther the shuttle vector pACYC184 or the suicide vector
pASK5 [29]. Although these attempts were not success-
ful, we would predict that such a complement would
correct the phenotypes reported herein similarly to the
previous reports.
In addition to the impact of tonB mutation on heme
source utilization, we and others have previously shown
that utilization of many of these heme sources is
abrogated by mutations in specific TBDTs [6–8,30]. For
example utilization of heme-HSA is dependent on
a functional HxuC protein [8], and the utilization
of hemoglobin-haptoglobin complexes requires theFigure 3 – Percentage of middle ear effusions with detectable wildty
infected with a mixture of equal numbers of the wildtype strain 86-028NP
the wild type strain (black columns) or the mutant strain (grey columns). U
detectable wildtype or mutant strains P< 0.008 on all days.presence of a functional hemoglobin-haptoglobin bind-
ing protein (HgpA, HgpB, or HgpC) [6,25].
Having established that the tonB mutant strain exhib-
ited the expected in vitro phenotype, we compared the
mutant and wildtype strains for their respective abilities
to establish and maintain infection of the middle ear in
chinchilla models of otitis media.
The TonB protein has previously been shown to be es-
sential for virulence of H. influenzae type b strains in the
infant rat model of bacteremia [17]. However, there have
been no reports of the impact of tonB mutations on
virulence in other clinically relevant models of H. influ-
enzae disease, including models of otitis media. Two
separate experiments were performed, one to assess the
impact of the tonB mutation on virulence by comparison
of two groups of chinchillas infected with individual
strains, and the second to assess the impact of the muta-
tion on competitive fitness by infection of a cohort of
animals with equal numbers of both strains.
In our virulence study experiment, two groups of five
chinchillas were transbullarly infected bilaterally with ei-
ther the wildtype strain 86-028NP or the isogenic tonB
mutant HI2280 (actual infective doses were 1,880 c.f.u.
for 86-028NP and 1,150 c.f.u. for HI2280). On day 4 post
challenge 9 of 9 successfully tapped ears challenged with
the wildtype strain yielded effusions. When animals were
challenged with the tonB mutant a different result oc-
curred. Five of 10 successfully tapped ears were dry in
the tonB mutant challenged cohort (Figure 2A). All MEE
recovered from the wildtype infected ears on day 4pe or mutant bacteria. Percentage of successfully tapped ears
and the tonB mutant strain HI2280 containing detectable colonies of
sing Fisher’s Exact test to compare percentages of effusions with
Morton et al. BMC Research Notes 2012, 5:327 Page 6 of 7
http://www.biomedcentral.com/1756-0500/5/327yielded bacterial titers in the range 5 x 106 to 4 x 108 c.f.
u. ml -1 (average titer 6.3 x 107 ± 1.3 x 108 c.f.u. ml -1). In
contrast the five MEEs recovered from mutant-
challenged ears on day 4 yielded no colonies on culture
under either aerobic or anaerobic conditions (Figure 2B).
Anaerobic conditions were used in addition to aerobic
since H. influenzae does not require heme for anaerobic
growth [5] and on no occasion was there any difference
in titers determined in the two growth conditions. On
days 7, 10, 14 and 17 post-infection, all of the success-
fully tapped ears challenged with the tonB mutant were
dry. In contrast, in ears challenged with the wildtype
strain the majority yielded a MEE over the same time
period, with average bacterial titers consistently in the
106 to 108 range (Figure 2). In addition, on day 17 five of
the mutant challenged ears were lavaged with 200 μl of
0.1 % gelatin in PBS. None of the five lavage fluids from
ears infected with the mutant strain yielded detectable
bacteria on either aerobic or anaerobic culture. On day
17 all animals were killed and the bullae were excised
from selected animals. Bullae were excised from four
ears challenged with the wildtype strain as well as from
all unlavaged ears challenged with the tonB mutant
strain. On macroscopic examination of the four bullae
excised from wildtype infected ears all contained dense
opaque material that has been termed biofilm and is
typically found in H. influenzae infected ears at 7 days
post-infection and beyond [31,32]. In contrast, on macro-
scopic examination of the five bullae excised from the
mutant infected animals none contained similar material
(data not shown).
A second experiment was designed to assess competi-
tive fitness of the wildtype and tonB mutant when the
two strains were used to co-challenge chinchilla ears. A
group of 5 chinchillas was infected transbullarly with
equal numbers of 86-028NP and tonB mutant cells (ac-
tual infective dose 4330 c.f.u equally divided between the
two strains). On days 7, 11 and 15 all ears were positive
for the presence of MEE while on days 4 and 18 respect-
ively 90 % and 75 % had MEE. In all MEE only the wild-
type strain was detected with average titers ranging from
2.1 x 108 ±2.1 x 108 to 2.6 x 106 ±2.4 x 107; no bacteria
were detected on media containing zeocin under either
aerobic or anaerobic incubation (Figure 3). These data
allow quantification of differential fitness between strains
by calculation of CI. CI is defined as the mutant/wild-
type ratio in the output sample divided by the same ratio
in the inoculum . The CI for all ears at all time-points
was 0; a CI of 1 would indicate that the mutant strain is
able to grow as well as the wildtype strain and a CI< 1
indicates that mutant growth is attenuated. Thus, in this
case the mutant is significantly attenuated in comparison
to the wildtype strain. Using Fisher’s Exact test to com-
pare percentages of effusions with detectable wildtype ormutant strains on day 4 P< 0.0001, on day 7 P= 0.0006,
on day 10 P= 0.0079, on day 14 P= 0.0002 and on day
17 P= 0.0022. P values vary since ears which yielded no
effusion or insufficient volume to analyze are excluded
from the analysis, thus sample numbers vary by day.
Thus, under identical in vivo conditions the wildtype
strain markedly out competed its isogenic tonB mutant.
Conclusions
These data demonstrate that expression of TonB is
essential for both virulence and competitive fitness of a
nontypeable H. influenzae strain in a chinchilla model of
otitis media. It has previously been shown that a tonB
mutant of a type b strain is avirulent in the infant-rat
model of invasive disease. Thus TonB is essential for
establishment of H. influenzae disease in multiple clinic-
ally relevant animal models of H. influenzae disease.
Since TonB is required for the function of TBDTs and
all of the H. influenzae TBDTs appear to be involved
in acquisition of heme these data indicate that heme
acquisition is an essential process during infection
caused by H. influenzae. This observation is further sup-
ported by the reports of the impact of mutations in
specific H. influenzae TBDTs, including the hemoglobin-
haptoglobin binding proteins (Hgps) and the heme-
hemopexin acquisition protein (HxuC), on virulence in
animal models [12,13].
In conclusion expression of TonB is required for the
establishment and maintenance of infection in an animal
model of H. influenzae otitis media.
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